Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

148 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group.
Levy Y, Capitant C, Houhou S, Carriere I, Viard JP, Goujard C, Gastaut JA, Oksenhendler E, Boumsell L, Gomard E, Rabian C, Weiss L, Guillet JG, Delfraissy JF, Aboulker JP, Seligmann M. Levy Y, et al. Among authors: aboulker jp. Lancet. 1999 Jun 5;353(9168):1923-9. doi: 10.1016/s0140-6736(98)07345-0. Lancet. 1999. PMID: 10371571 Clinical Trial.
Didanosine for zidovudine-intolerant patients with HIV disease.
Darbyshire JH, Aboulker JP. Darbyshire JH, et al. Among authors: aboulker jp. Lancet. 1992 Nov 28;340(8831):1346-7. doi: 10.1016/0140-6736(92)92524-j. Lancet. 1992. PMID: 1360049 Clinical Trial. No abstract available.
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.
INITIO Trial International Co-ordinating Committee, Yeni P, Cooper DA, Aboulker JP, Babiker AG, Carey D, Darbyshire JH, Floridia M, Girard PM, Goodall RL, Hooker MH, Mijch A, Meiffredy V, Salzberger B. INITIO Trial International Co-ordinating Committee, et al. Among authors: aboulker jp. Lancet. 2006 Jul 22;368(9532):287-98. doi: 10.1016/S0140-6736(06)69074-0. Lancet. 2006. PMID: 16860698 Clinical Trial.
Drug-resistant genotyping in HIV-1 therapy.
Aboulker JP. Aboulker JP. Lancet. 1999 Sep 25;354(9184):1120. doi: 10.1016/S0140-6736(99)00322-0. Lancet. 1999. PMID: 10509521 No abstract available.
Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.
Samri A, Durier C, Urrutia A, Sanchez I, Gahery-Segard H, Imbart S, Sinet M, Tartour E, Aboulker JP, Autran B, Venet A; ANRS ELISpot Standardization Group. Samri A, et al. Among authors: aboulker jp. Clin Vaccine Immunol. 2006 Jun;13(6):684-97. doi: 10.1128/CVI.00387-05. Clin Vaccine Immunol. 2006. PMID: 16760328 Free PMC article.
Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.
Aboulker JP, Babiker A, Chaix ML, Compagnucci A, Darbyshire J, Debré M, Faye A, Giaquinto C, Gibb DM, Harper L, Saïdi Y, Walker AS; Paediatric European Network for Treatment of AIDS. Aboulker JP, et al. AIDS. 2004 Jan 23;18(2):237-45. doi: 10.1097/00002030-200401230-00013. AIDS. 2004. PMID: 15075541 Clinical Trial.
148 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page